DEF 14AThe Ballot
Keros Therapeutics, Inc. files DEF 14A
Filed Apr 19, 2021 · 5y ago · Accession 0001104659-21-051967
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Keros Therapeutics, Inc.
- Ticker
- KROS
- CIK
- 1664710
- Form type
- DEF 14A
- Filing date
- Apr 19, 2021
- Report date
- Jun 1, 2021
- Document
- tm2112429-1_def14a.htm
- Size
- 2.3 MB